ANI Pharmaceuticals, Inc.
ANIP
$70.10
-$0.14-0.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 376.96M | 326.06M | 294.72M | 271.47M | 223.52M |
| Total Receivables | 274.47M | 255.43M | 281.08M | 252.62M | 225.65M |
| Inventory | 143.15M | 143.47M | 143.07M | 146.48M | 138.32M |
| Prepaid Expenses | 30.62M | 21.89M | 22.99M | 18.35M | 14.81M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 235.00K | 236.00K | 11.26M | 9.49M | 336.00K |
| Total Current Assets | 825.43M | 747.08M | 753.12M | 698.40M | 602.63M |
|
|
|||||
| Total Current Assets | 825.43M | 747.08M | 753.12M | 698.40M | 602.63M |
| Net Property, Plant & Equipment | 73.22M | 67.12M | 62.48M | 63.56M | 59.25M |
| Long-term Investments | 62.48M | 62.48M | 62.48M | 62.48M | 60.53M |
| Goodwill | 62.48M | 62.48M | 62.48M | 62.48M | 60.53M |
| Total Other Intangibles | 449.86M | 467.16M | 479.53M | 499.82M | 520.32M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 83.12M | 78.13M | 81.13M | 81.66M | 100.27M |
| Total Assets | 1.49B | 1.42B | 1.44B | 1.41B | 1.34B |
|
|
|||||
| Total Accounts Payable | 73.83M | 69.69M | 62.58M | 69.80M | 54.57M |
| Total Accrued Expenses | 140.95M | 102.17M | 144.32M | 135.45M | 116.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.33M | 19.30M | 19.30M | 15.24M | 13.22M |
| Total Finance Division Other Current Liabilities | 47.55M | 48.35M | 51.91M | 50.07M | 52.46M |
| Total Other Current Liabilities | 47.55M | 48.35M | 51.91M | 50.07M | 52.46M |
| Total Current Liabilities | 283.66M | 239.51M | 278.11M | 270.56M | 236.84M |
|
|
|||||
| Total Current Liabilities | 283.66M | 239.51M | 278.11M | 270.56M | 236.84M |
| Long-Term Debt | 589.16M | 594.46M | 599.77M | 605.07M | 608.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.54M | 16.45M | 9.22M | 11.27M | 6.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.55M | 9.25M | 12.55M | 15.44M | 29.52M |
| Total Liabilities | 896.90M | 859.67M | 899.65M | 902.34M | 881.39M |
|
|
|||||
| Common Stock & APIC | 620.25M | 608.43M | 596.04M | 586.23M | 541.90M |
| Retained Earnings | 31.10M | 6.39M | -23.10M | -50.59M | -76.86M |
| Treasury Stock & Other | -54.14M | -52.53M | -32.22M | -29.83M | -28.28M |
| Total Common Equity | 597.21M | 562.30M | 540.72M | 505.82M | 436.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 24.85M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 24.85M |
|
|
|||||
| Total Common Equity | 597.21M | 562.30M | 540.72M | 505.82M | 436.76M |
| Total Preferred Equity | -- | -- | -- | -- | 24.85M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 597.21M | 562.30M | 540.72M | 505.82M | 461.61M |
|
|
|||||